Quantbot Technologies LP Cassava Sciences Inc Transaction History

Quantbot Technologies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$16.64 - $25.32 $267,754 - $407,424	16,091 New	16,091 $267,000
Q3 2022 Nov 07, 2022	BUY	$16.33 - $51.06 $1,632 - $5,106	100 New	100 $4,000
Q1 2021 May 14, 2021	SELL	$7.09 - $87.95 $35,499 - $440,365	-5,007 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$6.79 - $12.25 $33,997 - $61,335	5,007 New	5,007 $34,000

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.